Lazard Asset Management LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$17.63 - $21.74 $63,591 - $78,416
3,607 New
3,607 $71,000
Q3 2023

Nov 14, 2023
BUY
$13.62 - $20.2 $47,697 - $70,740
3,502 New
3,502 $60,000
Q4 2022

Feb 14, 2023
BUY
$11.42 - $17.05 $53,080 - $79,248
4,648 New
4,648 $69,000
Q2 2022

Aug 09, 2022
BUY
$7.6 - $11.41 $36,677 - $55,064
4,826 Added 84.37%
10,546 $102,000
Q1 2022

May 13, 2022
BUY
$9.3 - $12.37 $18,237 - $24,257
1,961 Added 52.17%
5,720 $56,000
Q4 2021

Feb 09, 2022
BUY
$10.39 - $15.15 $39,056 - $56,948
3,759 New
3,759 $44,000

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $687M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email